Position in AZN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,227,298
-$484,532 QoQ
Shares Held
85,578
+1.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#252
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestmark Advisory Solutions, Inc. holds $211,410,302 across 13 Drug Manufacturers - General names. AZN ranks #4 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
53,968 | $64,730,841 | |
| 2 | JNJ |
Johnson & Johnson
|
138,783 | $35,246,716 | |
| 3 | ABBV |
AbbVie Inc.
|
126,735 | $31,891,592 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
85,578 | $16,227,298 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,985 | $14,390,071 | |
| 6 | NVS |
Novartis AG
|
81,258 | $12,734,752 | |
| 7 | AMGN |
Amgen Inc
|
28,753 | $10,412,035 | |
| 8 | PFE |
Pfizer Inc
|
335,343 | $8,075,058 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,227,298 | 85,578 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $16,711,830 | 84,737 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||